Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2320 (LINC02320)

Target
LINC02320
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2320 (LINC02320) is a long non-coding RNA located on chromosome 14 and primarily classified as a lincRNA. It is highly expressed in colorectal cancer, especially metastatic lesions. LINC02320 promotes cancer cell proliferation, migration, and metastasis while inhibiting apoptosis. Mechanistically, it acts as a molecular scaffold in the nucleus, recruiting the transcription regulator ILF2 to the GRB7 gene promoter, thus activating GRB7 transcription and the MAPK signaling pathway. This pathway enhances downstream signaling, facilitating tumor growth and forming a positive feedback loop with the transcription factor FOS, which further upregulates LINC02320. Therapeutically, antisense oligonucleotides targeting LINC02320 have shown efficacy in blocking tumor growth in preclinical models, identifying it as a promising target for intervention in metastatic colorectal cancer

Other names
LINC02320long intergenic non-coding RNA 2320
02

Mechanism of action

Antisense inhibition of lncRNA function (results in impaired proliferation, migration, and tumor growth)

03

Biological functions

Regulation of transcriptionPromotion of cell proliferationEnhancement of metastasis (migration and invasion)Inhibition of apoptosisScaffold for recruitment of transcriptional regulators
04

Disease associations

CancerColorectal cancer (especially metastatic)Non-small cell lung cancer (expression noted, role less defined)
05

Safety considerations

None specifically reported; general challenges for lncRNA-targeted therapies include specificity, effective delivery, and off-target effects
06

Interacting drugs

Antisense oligonucleotides targeting LINC02320
07

Biomarkers

High LINC02320 expression associated with advanced stage, metastasis, and poor prognosis in colorectal cancer

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2320 (LINC02320).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2320 (LINC02320).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call